4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-066050
President & CEO sold 83,333 shares at $55.69 ($4,640,815)
- President & CEO acquired 83,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…